Immunostimulant-encoded mRNAs, such as TriMix, induce tumor cell death and release tumor antigens or are coupled with multiple-TAA-encoded mRNAs that produce robust CD8+ T-cell responses to improve response rates in patients [122]. This evidence concerns the gene CD8A and neoplasm.